These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33511237)

  • 1. Integrase Strand Transfer Inhibitors Play the Main Role in Greater Weight Gain Among Men With Acute and Early HIV Infection.
    Wu KS; Anderson C; Little SJ
    Open Forum Infect Dis; 2021 Jan; 8(1):ofaa619. PubMed ID: 33511237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy.
    Bourgi K; Rebeiro PF; Turner M; Castilho JL; Hulgan T; Raffanti SP; Koethe JR; Sterling TR
    Clin Infect Dis; 2020 Mar; 70(7):1267-1274. PubMed ID: 31100116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral Therapy Anchor-based Trends in Body Mass Index Following Treatment Initiation Among Military Personnel with HIV.
    Kline MDA; Daniels C; Xu X; Sunil T; Ganesan A; Agan BK; Colombo RE; Kronmann KC; Blaylock JM; Okulicz JF; Markelz AE
    Mil Med; 2021 Feb; 186(3-4):279-285. PubMed ID: 33128552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment.
    Mocroft A; Neesgard B; Zangerle R; Rieger A; Castagna A; Spagnuolo V; Antinori A; Lampe FC; Youle M; Vehreschild JJ; Mussini C; Borghi V; Begovac J; Duvivier C; Gunthard HF; Rauch A; Tiraboschi J; Chkhartishvili N; Bolokadze N; Wit F; Wasmuth JC; De Wit S; Necsoi C; Pradier C; Svedhem V; Stephan C; Petoumenos K; Garges H; Rogatto F; Peters L; Ryom L;
    HIV Med; 2020 Oct; 21(9):599-606. PubMed ID: 32588958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study.
    Serrano-Villar S; Martínez-Sanz J; Ron R; Talavera-Rodríguez A; Fernández-Felix BM; Herrera S; Muriel A; Fanjul F; Portilla J; Muñoz J; Amador C; de Zárraga MA; Vivancos MJ; Moreno S;
    Lancet HIV; 2020 Aug; 7(8):e565-e573. PubMed ID: 32763219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INSTI-Based Initial Antiretroviral Therapy in Adults with HIV, the HIV Outpatient Study, 2007-2018.
    Mayer S; Rayeed N; Novak RM; Li J; Palella FJ; Buchacz K;
    AIDS Res Hum Retroviruses; 2021 Oct; 37(10):768-775. PubMed ID: 34030459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight changes, metabolic syndrome and all-cause mortality among Asian adults living with HIV.
    Han WM; Law MG; Choi JY; Ditangco R; Kumarasamy N; Chaiwarith R; Ly PS; Khusuwan S; Merati TP; Do CD; Yunihastuti E; Azwa I; Lee MP; Pham TN; Chan YJ; Kiertiburanakul S; Ng OT; Tanuma J; Pujari S; Zhang F; Gani Y; Mave V; Ross J; Avihingsanon A;
    HIV Med; 2022 Mar; 23(3):274-286. PubMed ID: 34816562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological and virological efficacy of different antiretroviral regimens initiated during acute/recent HIV infection.
    Ambrosioni J; Farrera J; de Lazzari E; Nicolás D; Manzardo C; Hernández-Meneses MM; Mosquera MM; Ligero C; Marcos MA; Sánchez-Palomino S; Fernández E; Plana M; Miró JM;
    AIDS; 2020 Dec; 34(15):2269-2274. PubMed ID: 32910066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Assessment of Weight Change in People with HIV-1 After Initiating Integrase Strand Transfer Inhibitors or Protease Inhibitors.
    Chen YW; Hardy H; Pericone CD; Chow W
    J Health Econ Outcomes Res; 2020; 7(2):102-110. PubMed ID: 32766375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Assessment of Weight Change in African American Females and Hispanics with HIV-1 After Initiating Integrase Strand-Transfer Inhibitors or Protease Inhibitors.
    Chen YW; Anderson D; Pericone CD; Donga P
    J Health Econ Outcomes Res; 2022; 9(1):1-10. PubMed ID: 35083364
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effectiveness of antiretroviral drug classes for the treatment of HIV infection in patients with high viral loads: a multicentre retrospective cohort study.
    Adams JL; Murray M; Patel N; Sawkin MT; Boardman RC; Pham C; Kaur H; Patel D; Yager JL; Pontiggia L; Baxter J
    HIV Med; 2021 Jan; 22(1):28-36. PubMed ID: 32964664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?
    Milanés-Guisado Y; Gutiérrez-Valencia A; Muñoz-Pichardo JM; Rivero A; Trujillo-Rodriguez M; Ruiz-Mateos E; Espinosa N; Roca-Oporto C; Viciana P; López-Cortés LF
    J Antimicrob Chemother; 2020 Jan; 75(1):200-207. PubMed ID: 31617904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No overall impact on rate of weight gain with integrase inhibitor-containing regimens in antiretroviral-naïve adults.
    Burns JE; Stirrup O; Waters L; Dunn D; Gilson R; Pett SL
    HIV Med; 2022 Mar; 23(3):294-300. PubMed ID: 34634168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy.
    Lake JE; Wu K; Bares SH; Debroy P; Godfrey C; Koethe JR; McComsey GA; Palella FJ; Tassiopoulos K; Erlandson KM
    Clin Infect Dis; 2020 Dec; 71(9):e471-e477. PubMed ID: 32099991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participants.
    Verboeket SO; Boyd A; Wit FW; Verheij E; Schim van der Loeff MF; Kootstra N; van der Valk M; Reiss P;
    PLoS One; 2021; 16(5):e0251205. PubMed ID: 33951089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight Changes With Integrase Strand Transfer Inhibitor Therapy in the Management of HIV Infection: A Systematic Review.
    Hester EK; Greenlee S; Durham SH
    Ann Pharmacother; 2022 Feb; ():10600280211073321. PubMed ID: 35130714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapy.
    Gagliardini R; Gianotti N; Maggiolo F; Cozzi-Lepri A; Antinori A; Nozza S; Lapadula G; De Luca A; Mussini C; Gori A; Saracino A; Andreoni M; Monforte AD;
    Int J Antimicrob Agents; 2021 Oct; 58(4):106406. PubMed ID: 34293454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels.
    Lambert-Niclot S; Boyd A; Fofana D; Valin N; Wirden M; Meynard JL; Palich R; Agher R; Valantin MA; Calvez V; Katlama C; Girard PM; Marcelin AG; Morand-Joubert L
    Open Forum Infect Dis; 2019 May; 6(5):ofz177. PubMed ID: 31123690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergent drug resistance with integrase strand transfer inhibitor-based regimens.
    Lepik KJ; Harrigan PR; Yip B; Wang L; Robbins MA; Zhang WW; Toy J; Akagi L; Lima VD; Guillemi S; Montaner JSG; Barrios R
    AIDS; 2017 Jun; 31(10):1425-1434. PubMed ID: 28375875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.